HpVac Appoints Joana Vitte, MD, PhD, as Chief Scientific Officer
23 nov. 2022 04h00 HE
|
AKAMPION
- Significant expansion of allergy research expertise Geneva, Switzerland, November 23, 2022 – HpVac SA, a company developing novel preventive and therapeutic first-line therapies against...
Intrommune Therapeutics Completes Enrollment in the Phase 1 OMEGA Study for Peanut Allergy
26 oct. 2022 09h35 HE
|
Intrommune Therapeutics
Observed only mild and transient adverse events, with no use of emergency epinephrine Observed 98.4% patient compliance to date with novel OMIT therapeutic modality Safely started patients on dose...
HpVac Announces New Animal Data of its Lead Compound Demonstrating Protection Against Allergic Asthma
18 oct. 2022 04h00 HE
|
AKAMPION
- Major milestone for accelerating the development of HpVac-13 in allergic diseases Geneva, Switzerland, October 18, 2022 – HpVac SA, a company developing novel preventive and therapeutic...
Allersearch® Laboratories Lands Savvy Cleaner's CEO Angela Brown as Brand Ambassador
17 août 2022 13h01 HE
|
Savvy Cleaner
CHARLOTTE, N.C., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Allersearch® Laboratories, the New Jersey-based company behind pet dander allergy relief for the last four decades, has a new message for pet...
Historic Bill Will Help Over 60 Million People with Asthma and Allergies
12 août 2022 17h35 HE
|
Asthma and Allergy Foundation of America
Washington, D.C., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Today, Congress passed the Inflation Reduction Act. This bill makes significant investments to address the climate crisis and to improve access to...
AXIM Biotechnologies Celebrates Feature on the Vision is More Than 20/20™ Podcast
21 juil. 2022 09h00 HE
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, July 21, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting ocular...
Global Allergy Diagnostics Markets, 2022-2026 & 2031 with BioMerieux, Danaher, HOB Biotech Group, HYCOR Biomedical, & Lincoln Diagnostics Dominating
23 juin 2022 04h18 HE
|
Research and Markets
Dublin, June 23, 2022 (GLOBE NEWSWIRE) -- The "Allergy Diagnostics Global Market Report 2022, By Allergen, By Products, By End User" report has been added to ResearchAndMarkets.com's offering.The...
Intrommune Announces Expanded Scope of Phase 1 OMEGA Study in Adults with Peanut Allergy
22 juin 2022 09h31 HE
|
Intrommune Therapeutics
Amendment to Extend Study Duration to 48 weeks New Maintenance Period Is Designed to Evaluate Safety of INT301 After Long-term Exposure NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Intrommune...
AB Science annonce aujourd'hui la publication des résultats de son étude positive du masitinib dans l'asthme sévère non contrôlé par les corticostéroïdes oraux dans la revue évaluée par des pairs Journal of Asthma and Allergy
07 juin 2022 11h45 HE
|
AB Science
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE LA PUBLICATION DANS LA REVUE JOURNAL OF ASTHMA AND ALLERGY DES RÉSULTATS POSITIFS DE L'ETUDE DE PHASE 3 DU MASITINIB CHEZ LES PATIENTS SOUFFRANT D'ASTHME...
AB Science today announced publication of results from its positive study of masitinib in severe asthma uncontrolled by oral corticosteroids in the peer-reviewed Journal of Asthma and Allergy
07 juin 2022 11h45 HE
|
AB Science
PRESS RELEASE AB SCIENCE ANNOUNCES PUBLICATION IN THE JOURNAL OF ASTHMA AND ALLERGY OF POSITIVE MASITINIB PHASE 3 CLINICAL TRIAL RESULTS IN PATIENTS WITH ORAL CORTICOSTEROID-DEPENDENT SEVERE ASTHMA ...